Management of Palpitations in Fully Paced CRT-D Patients

Initial Diagnostic Approach

• The European Society of Cardiology recommends interrogating the CRT-D device immediately to determine the exact arrhythmia causing palpitations and verify the percentage of biventricular pacing 1, 2, 3
• The Heart Failure Society of America suggests reviewing device programming as any arrhythmic event should prompt this assessment 2, 3
• The American Heart Association recommends assessing for reversible triggers including volume overload, electrolyte disturbances, and loss of biventricular pacing 2, 4
• The European Society of Cardiology advises optimizing guideline-directed medical therapy for heart failure first, as this is mandatory not only to treat but also to prevent ventricular arrhythmias 2, 3, 5

Treatment Algorithm Based on Arrhythmia Type

• The American College of Cardiology recommends amiodarone if rhythm control strategy is chosen for atrial fibrillation, particularly to maintain sinus rhythm and achieve 100% biventricular pacing 1, 3, 5
• The Heart Rhythm Society suggests using bisoprolol or other beta-blockers as AV blocking medical therapy to maximize biventricular pacing even if AF persists 1, 3
• The European Heart Rhythm Association recommends considering AV nodal ablation if medical therapy fails to achieve sufficient biventricular pacing despite beta-blockers or amiodarone 1, 2, 3

Specific Medication Considerations

• The American Heart Association recommends using beta-blockers as first-line therapy for ventricular arrhythmias, particularly in patients with coronary artery disease or structural heart disease 6
• The European Society of Cardiology advises that amiodarone is one of few antiarrhythmic agents with neutral effects on mortality in heart failure patients 7
• The American College of Cardiology recommends regular monitoring of thyroid function, liver function, pulmonary function, and cardiac monitoring for bradycardia/heart block when using amiodarone 7

Monitoring After Initiation

• The Heart Failure Society of America recommends verifying biventricular pacing percentage at follow-up device interrogation to ensure therapy is effective 1, 2, 3
• The American Heart Association advises monitoring for amiodarone toxicity with regular thyroid, liver, and pulmonary assessments 7
• The European Society of Cardiology suggests assessing symptom improvement and quality of life, as rhythm control may improve LVEF, functional capacity, and quality of life compared to rate control 1, 3, 5